Yellow fever - Wikipedia Yellow fever For other uses of `` yellow fever '', see Yellow fever ( disambiguation ). `` American Plague '' redirects here. For the rock band, see The American Plague. `` Yellow plague '' redirects here. For the Yellow Plague of Rhos in medieval Wales, see Maelgwn Gwynedd. Yellow fever Synonyms Yellow jack, yellow plague, bronze john A TEM micrograph of the yellow fever virus ( 234,000 × magnification ) Specialty Infectious disease Symptoms Fever, chills, muscle pain, yellow skin Complications Liver failure, bleeding Usual onset 3 - 6 days post exposure Duration 3 - 4 days Causes Yellow fever virus spread by mosquitoes Diagnostic method Blood test Prevention Yellow fever vaccine Treatment Supportive care Frequency ~ 127,000 severe cases ( 2013 ) Deaths 5,100 ( 2015 ) ( edit on Wikidata ) Yellow fever is a viral disease of typically short duration. In most cases, symptoms include fever, chills, loss of appetite, nausea, muscle pains particularly in the back, and headaches. Symptoms typically improve within five days. In about 15 % of people within a day of improving, the fever comes back, abdominal pain occurs, and liver damage begins causing yellow skin. If this occurs, the risk of bleeding and kidney problems is also increased. The disease is caused by the yellow fever virus and is spread by the bite of an infected female mosquito. It infects only humans, other primates, and several species of mosquitoes. In cities, it is spread primarily by Aedes aegypti, a type of mosquito found throughout the tropics and subtropics. The virus is an RNA virus of the genus Flavivirus. The disease may be difficult to tell apart from other illnesses, especially in the early stages. To confirm a suspected case, blood sample testing with polymerase chain reaction is required. A safe and effective vaccine against yellow fever exists and some countries require vaccinations for travelers. Other efforts to prevent infection include reducing the population of the transmitting mosquito. In areas where yellow fever is common and vaccination is uncommon, early diagnosis of cases and immunization of large parts of the population is important to prevent outbreaks. Once infected, management is symptomatic with no specific measures effective against the virus. Death occurs in up to half of those who get severe disease. In 2013, yellow fever resulted in about 127,000 severe infections and 45,000 deaths, with nearly 90 % of these occurring in Africa. Nearly a billion people live in an area of the world where the disease is common. It is common in tropical areas of South America and Africa, but not in Asia. Since the 1980s, the number of cases of yellow fever has been increasing. This is believed to be due to fewer people being immune, more people living in cities, people moving frequently, and changing climate. The disease originated in Africa, from where it spread to South America through the slave trade in the 17th century. Since the 17th century, several major outbreaks of the disease have occurred in the Americas, Africa, and Europe. In the 18th and 19th centuries, yellow fever was seen as one of the most dangerous infectious diseases. In 1927 yellow fever virus became the first human virus to be isolated. Contents 1 Signs and symptoms 2 Cause 2.1 Transmission 3 Pathogenesis 4 Diagnosis 5 Prevention 5.1 Vaccination 5.2 Compulsory vaccination 5.3 Vector control 6 Treatment 7 Epidemiology 7.1 Africa 7.2 South America 7.3 Asia 8 History 9 Research 10 References 11 Further reading 12 External links Signs and symptoms Yellow fever begins after an incubation period of three to six days. Most cases only cause a mild infection with fever, headache, chills, back pain, fatigue, loss of appetite, muscle pain, nausea, and vomiting. In these cases, the infection lasts only three to four days. In 15 % of cases, however, people enter a second, toxic phase of the disease with recurring fever, this time accompanied by jaundice due to liver damage, as well as abdominal pain. Bleeding in the mouth, the eyes, and the gastrointestinal tract cause vomit containing blood, hence the Spanish name for yellow fever, vómito negro ( `` black vomit '' ). There may also be kidney failure, hiccups, and delirium. The toxic phase is fatal in about 20 to 50 % of cases, making the overall fatality rate for the disease about 3.0 to 7.5 %. However, the fatality rate of those with the toxic phase of the disease may exceed 50 %. Surviving the infection provides lifelong immunity, and normally no permanent organ damage results. Cause Yellow fever virus Virus classification Group : Group IV ( ( + ) ssRNA ) Order : Unassigned Family : Flaviviridae Genus : Flavivirus Species : Yellow fever virus Yellow fever is caused by the yellow fever virus, a 40 -- to 50 - nm - wide enveloped RNA virus, the type species and namesake of the family Flaviviridae. It was the first illness shown to be transmissible by filtered human serum and transmitted by mosquitoes, by Walter Reed around 1900. The positive - sense, single - stranded RNA is around 11,000 nucleotides long and has a single open reading frame encoding a polyprotein. Host proteases cut this polyprotein into three structural ( C, prM, E ) and seven nonstructural proteins ( NS1, NS2A, NS2B, NS3, NS4A, NS4B, NS5 ) ; the enumeration corresponds to the arrangement of the protein coding genes in the genome. Minimal yellow fever virus ( YFV ) 3'UTR region is required for stalling of the host 5 ' - 3 ' exonuclease XRN1. The UTR contains PKS3 pseudoknot structure which serves as a molecular signal to stall the exonuclease and is the only viral requirement for subgenomic flavivirus RNA ( sfRNA ) production. The sfRNAs are a result of incomplete degradation of the viral genome by the exonuclease and are important for viral pathogenicity. Yellow fever belongs to the group of hemorrhagic fevers. The viruses infect, amongst others, monocytes, macrophages, and dendritic cells. They attach to the cell surface via specific receptors and are taken up by an endosomal vesicle. Inside the endosome, the decreased pH induces the fusion of the endosomal membrane with the virus envelope. The capsid enters the cytosol, decays, and releases the genome. Receptor binding, as well as membrane fusion, are catalyzed by the protein E, which changes its conformation at low pH, causing a rearrangement of the 90 homo dimers to 60 homo trimers. After entering the host cell, the viral genome is replicated in the rough endoplasmic reticulum ( ER ) and in the so - called vesicle packets. At first, an immature form of the virus particle is produced inside the ER, whose M - protein is not yet cleaved to its mature form and is therefore denoted as prM ( precursor M ) and forms a complex with protein E. The immature particles are processed in the Golgi apparatus by the host protein furin, which cleaves prM to M. This releases E from the complex which can now take its place in the mature, infectious virion. Transmission Aedes aegypti feeding Adults of the yellow fever mosquito A. aegypti : The male is on the left, females are on the right. Only the female mosquito bites humans to transmit the disease. Yellow fever virus is mainly transmitted through the bite of the yellow fever mosquito Aedes aegypti, but other mostly Aedes mosquitoes such as the tiger mosquito ( Aedes albopictus ) can also serve as a vector for this virus. Like other arboviruses which are transmitted by mosquitoes, the yellow fever virus is taken up by a female mosquito when it ingests the blood of an infected human or other primate. Viruses reach the stomach of the mosquito, and if the virus concentration is high enough, the virions can infect epithelial cells and replicate there. From there, they reach the haemocoel ( the blood system of mosquitoes ) and from there the salivary glands. When the mosquito next sucks blood, it injects its saliva into the wound, and the virus reaches the bloodstream of the bitten person. Transovarial and transstadial transmission of the yellow fever virus within A. aegypti, that is, the transmission from a female mosquito to her eggs and then larvae, are indicated. This infection of vectors without a previous blood meal seems to play a role in single, sudden breakouts of the disease. Three epidemiologically different infectious cycles occur, in which the virus is transmitted from mosquitoes to humans or other primates. In the `` urban cycle '', only the yellow fever mosquito A. aegypti is involved. It is well adapted to urban areas and can also transmit other diseases, including Zika fever, dengue fever, and chikungunya. The urban cycle is responsible for the major outbreaks of yellow fever that occur in Africa. Except in an outbreak in 1999 in Bolivia, this urban cycle no longer exists in South America. Besides the urban cycle, both in Africa and South America, a sylvatic cycle ( forest or jungle cycle ) is present, where Aedes africanus ( in Africa ) or mosquitoes of the genus Haemagogus and Sabethes ( in South America ) serve as vectors. In the jungle, the mosquitoes infect mainly non-human primates ; the disease is mostly asymptomatic in African primates. In South America, the sylvatic cycle is currently the only way humans can become infected, which explains the low incidence of yellow fever cases on the continent. People who become infected in the jungle can carry the virus to urban areas, where A. aegypti acts as a vector. Because of this sylvatic cycle, the yellow fever can not be eradicated. In Africa, a third infectious cycle known as `` savannah cycle '' or intermediate cycle, occurs between the jungle and urban cycles. Different mosquitoes of the genus Aedes are involved. In recent years, this has been the most common form of transmission of yellow fever in Africa. Concern exists about yellow fever spreading to southeast Asia, where its vector A. aegypti already occurs. Pathogenesis After transmission from a mosquito, the viruses replicate in the lymph nodes and infect dendritic cells in particular. From there, they reach the liver and infect hepatocytes ( probably indirectly via Kupffer cells ), which leads to eosinophilic degradation of these cells and to the release of cytokines. Apoptotic masses known as Councilman bodies appear in the cytoplasm of hepatocytes. Fatality may occur when cytokine storm, shock, and multiple organ failure follow. Diagnosis Yellow fever is most frequently a clinical diagnosis, made on the basis of symptoms and the diseased person 's whereabouts prior to becoming ill. Mild courses of the disease can only be confirmed virologically. Since mild courses of yellow fever can also contribute significantly to regional outbreaks, every suspected case of yellow fever ( involving symptoms of fever, pain, nausea and vomiting six to 10 days after leaving the affected area ) is treated seriously. If yellow fever is suspected, the virus can not be confirmed until six to 10 days after the illness. A direct confirmation can be obtained by reverse transcription polymerase chain reaction where the genome of the virus is amplified. Another direct approach is the isolation of the virus and its growth in cell culture using blood plasma ; this can take one to four weeks. Serologically, an enzyme linked immunosorbent assay during the acute phase of the disease using specific IgM against yellow fever or an increase in specific IgG - titer ( compared to an earlier sample ) can confirm yellow fever. Together with clinical symptoms, the detection of IgM or a fourfold increase in IgG - titer is considered sufficient indication for yellow fever. Since these tests can cross-react with other flaviviruses, like dengue virus, these indirect methods can not conclusively prove yellow fever infection. Liver biopsy can verify inflammation and necrosis of hepatocytes and detect viral antigens. Because of the bleeding tendency of yellow fever patients, a biopsy is only advisable post mortem to confirm the cause of death. In a differential diagnosis, infections with yellow fever must be distinguished from other feverish illnesses like malaria. Other viral hemorrhagic fevers, such as Ebola virus, Lassa virus, Marburg virus, and Junin virus, must be excluded as cause. Prevention Personal prevention of yellow fever includes vaccination and avoidance of mosquito bites in areas where yellow fever is endemic. Institutional measures for prevention of yellow fever include vaccination programmes and measures of controlling mosquitoes. Programmes for distribution of mosquito nets for use in homes are providing reductions in cases of both malaria and yellow fever. Use of EPA - registered insect repellent is recommended when outdoors. Exposure for even a short time is enough for a potential mosquito bite. Long - sleeved clothing, long pants, and socks are useful for prevention. The awareness of peak mosquito exposure is from dusk to dawn. The application of larvicides to water - storage containers can help eliminate potential mosquito breeding sites. Adult mosquitos can be killed through insecticide spray usage, which decreases the transmission of yellow fever. Use insect repellent when outdoors such as those containing DEET, picaridin, IR3535, or oil of lemon eucalyptus on exposed skin. Wear proper clothing to reduce mosquito bites. When weather permits, wear long sleeves, long pants and socks when outdoors. Mosquitoes may bite through thin clothing, so spraying clothes with repellent containing permethrin or another EPA - registered repellent will give extra protection. Clothing treated with permethrin is commercially available. Mosquito repellents containing permethrin are not approved for application directly to skin. The peak biting times for many mosquito species are dusk to dawn. However, A. aegypti, one of the mosquitoes that transmits yellow fever virus, feeds during the daytime. Staying in accommodations with screened or air - conditioned rooms, particularly during peak biting times, also reduces risk of mosquito bites. Vaccination The cover of a certificate that confirms the holder has been vaccinated against yellow fever Main article : Yellow fever vaccine Vaccination is recommended for those traveling to affected areas, because non-native people tend to develop more severe illness when infected. Protection begins by the 10th day after vaccine administration in 95 % of people, and had been reported to last for at least 10 years. WHO now states that a single dose of vaccination is sufficient to confer lifelong immunity against yellow fever disease. '' The attenuated live vaccine stem 17D was developed in 1937 by Max Theiler. The World Health Organization ( WHO ) recommends routine vaccinations for people living in affected areas between the 9th and 12th month after birth. Up to one in four people experience fever, aches, and local soreness and redness at the site of injection. In rare cases ( less than one in 200,000 to 300,000 ), the vaccination can cause yellow fever vaccine -- associated viscerotropic disease, which is fatal in 60 % of cases. It is probably due to the genetic morphology of the immune system. Another possible side effect is an infection of the nervous system, which occurs in one in 200,000 to 300,000 cases, causing yellow fever vaccine - associated neurotropic disease, which can lead to meningoencephalitis and is fatal in less than 5 % of cases. The Yellow Fever Initiative, launched by WHO in 2006, vaccinated more than 105 million people in 14 countries in West Africa. No outbreaks were reported during 2015. The campaign was supported by the GAVI Alliance, and governmental organizations in Europe and Africa. According to the WHO, mass vaccination can not eliminate yellow fever because of the vast number of infected mosquitoes in urban areas of the target countries, but it will significantly reduce the number of people infected. In March 2017, WHO launched a vaccination campaign in Brazil with 3.5 million doses from an emergency stockpile. In March 2017 the WHO recommended vaccination for travellers to certain parts of Brazil. Compulsory vaccination Some countries in Asia are theoretically in danger of yellow fever epidemics ( mosquitoes with the capability to transmit yellow fever and susceptible monkeys are present ), although the disease does not yet occur there. To prevent introduction of the virus, some countries demand previous vaccination of foreign visitors if they have passed through yellow fever areas. Vaccination has to be proved by production of a vaccination certificate which is valid 10 days after the vaccination and lasts for 10 years. Although the WHO on 17 May 2013 advised that subsequent booster vaccinations are unnecessary, an older ( than 10 years ) certificate may not be acceptable at all border posts in all affected countries. A list of the countries that require yellow fever vaccination is published by the WHO. If the vaccination can not be conducted for some reasons, dispensation may be possible. In this case, an exemption certificate issued by a WHO - approved vaccination center is required. Although 32 of 44 countries where yellow fever occurs endemically do have vaccination programmes, in many of these countries, less than 50 % of their population is vaccinated. Vector control Information campaign for prevention of dengue and yellow fever in Paraguay Control of the yellow fever mosquito A. aegypti is of major importance, especially because the same mosquito can also transmit dengue fever and chikungunya disease. A. aegypti breeds preferentially in water, for example in installations by inhabitants of areas with precarious drinking water supply, or in domestic waste, especially tires, cans, and plastic bottles. These conditions are common in urban areas in developing countries. Two main strategies are employed to reduce mosquito populations. One approach is to kill the developing larvae. Measures are taken to reduce the water accumulations in which the larva develops. Larvicides are used, as well as larvae - eating fish and copepods, which reduce the number of larvae. For many years, copepods of the genus Mesocyclops have been used in Vietnam for preventing dengue fever. It eradicated the mosquito vector in several areas. Similar efforts may be effective against yellow fever. Pyriproxyfen is recommended as a chemical larvicide, mainly because it is safe for humans and effective even in small doses. The second strategy is to reduce populations of the adult yellow fever mosquito. Lethal ovitraps can reduce Aedes populations, but with a decreased amount of pesticide because it targets the mosquitoes directly. Curtains and lids of water tanks can be sprayed with insecticides, but application inside houses is not recommended by the WHO. Insecticide - treated mosquito nets are effective, just as they are against the Anopheles mosquito that carries malaria. Treatment As for other flavivirus infections, no cure is known for yellow fever. Hospitalization is advisable and intensive care may be necessary because of rapid deterioration in some cases. Different methods for acute treatment of the disease have been shown not to be very successful ; passive immunisation after emergence of symptoms is probably without effect. Ribavirin and other antiviral drugs, as well as treatment with interferons, do not have a positive effect in patients. A symptomatic treatment includes rehydration and pain relief with drugs such as paracetamol ( acetaminophen in the United States ). Acetylsalicylic acid ( aspirin ) should not be given because of its anticoagulant effect, which can be devastating in the case of internal bleeding that can occur with yellow fever. Epidemiology Yellow fever is common in tropical and subtropical areas of South America and Africa. Worldwide, about 600 million people live in endemic areas. The WHO estimates 200,000 cases of disease and 30,000 deaths a year occur ; the number of officially reported cases is far lower. Africa Endemic range of yellow fever in Africa ( 2009 ) An estimated 90 % of the infections occur on the African continent. In 2008, the largest number of recorded cases was in Togo. In 2016, a large outbreak originated in Angola and spread to neighboring countries before being contained by a massive vaccination campaign. In March and April, 11 cases were reported in China, the first appearance of the disease in Asia in recorded history. Phylogenetic analysis has identified seven genotypes of yellow fever viruses, and they are assumed to be differently adapted to humans and to the vector A. aegypti. Five genotypes ( Angola, Central / East Africa, East Africa, West Africa I, and West Africa II ) occur only in Africa. West Africa genotype I is found in Nigeria and the surrounding areas. This appears to be especially virulent or infectious, as this type is often associated with major outbreaks. The three genotypes in East and Central Africa occur in areas where outbreaks are rare. Two recent outbreaks in Kenya ( 1992 -- 1993 ) and Sudan ( 2003 and 2005 ) involved the East African genotype, which had remained unknown until these outbreaks occurred. South America Endemic range of yellow fever in South America ( 2009 ) In South America, two genotypes have been identified ( South American genotypes I and II ). Based on phylogenetic analysis these two genotypes appear to have originated in West Africa and were first introduced into Brazil. The date of introduction into South America appears to be 1822 ( 95 % confidence interval 1701 to 1911 ). The historical record shows an outbreak of yellow fever occurred in Recife, Brazil, between 1685 and 1690. The disease seems to have disappeared, with the next outbreak occurring in 1849. It was likely introduced with the importation of slaves through the slave trade from Africa. Genotype I has been divided into five subclades, A through E. In late 2016, a large outbreak began in Minas Gerais state of Brazil that was characterized as a sylvan or jungle epizootic. It began as an outbreak in brown howler monkeys, which serve as a sentinel species for yellow fever, that then spread to men working in the jungle. No cases had been transmitted between humans by the Aedes aegypti mosquito, which can sustain urban outbreaks that can spread rapidly. In April 2017, the sylvan outbreak continued moving toward the Brazilian coast where most people were unvaccinated. By the end of May the outbreak appeared to be declining after more than 3,000 suspected cases, 758 confirmed and 264 deaths confirmed to be yellow fever. The Health Ministry launched a vaccination campaign and was concerned about spread during the Carnival season in February and March. The CDC issued a Level 2 alert ( practice enhanced precautions. ) A Bayesian analysis of genotypes I and II has shown that genotype I accounts for virtually all the current infections in Brazil, Colombia, Venezuela and Trinidad and Tobago while genotype II accounted for all cases in Peru. Genotype I originated in the Northern Brazilian region around 1908 ( 95 % HPD : 1870 -- 1936 ). Genotype II originated in Peru in 1920 ( 95 % HPD : 1867 -- 1958 ). The estimated rate of mutation for both genotypes was ~ 5 × 10 substitutions / site / year, similar to that of other RNA viruses. Asia Though the main vector ( A. aegypti ) also occurs in tropical and subtropical regions of Asia, the Pacific, and Australia, yellow fever has never occurred in these parts of the globe until the introduction of 11 cases by jet travel from an outbreak in Africa in 2016. Proposed explanations include the idea that the strains of the mosquito in the east are less able to transmit the yellow fever virus, that immunity is present in the populations because of other diseases caused by related viruses ( for example, dengue ), and that the disease was never introduced because the shipping trade was insufficient, but none is considered satisfactory. Another proposal is the absence of a slave trade to Asia on the scale of that to the Americas. The trans - Atlantic slave trade was probably the means of introduction into the Western Hemisphere from Africa. History Main articles : History of yellow fever and Timeline of yellow fever Carlos Finlay Walter Reed The evolutionary origins of yellow fever most likely lie in Africa, with transmission of the disease from nonhuman primates to humans. The virus is thought to have originated in East or Central Africa and spread from there to West Africa. As it was endemic in Africa, the natives had developed some immunity to it. When an outbreak of yellow fever would occur in an African village where colonists resided, most Europeans died, while the native population usually suffered nonlethal symptoms resembling influenza. This phenomenon, in which certain populations develop immunity to yellow fever due to prolonged exposure in their childhood, is known as acquired immunity. The virus, as well as the vector A. aegypti, were probably transferred to North and South America with the importation of slaves from Africa, part of the Columbian Exchange following European exploration and colonization. The first definitive outbreak of yellow fever in the New World was in 1647 on the island of Barbados. An outbreak was recorded by Spanish colonists in 1648 in the Yucatán Peninsula, where the indigenous Mayan people called the illness xekik ( `` blood vomit '' ). In 1685, Brazil suffered its first epidemic, in Recife. The first mention of the disease by the name `` yellow fever '' occurred in 1744. McNeill argues that the environmental and ecological disruption caused by the introduction of sugar plantations created the conditions for mosquito and viral reproduction, and subsequent outbreaks of yellow fever. Deforestation reduced populations of insectivorous birds and other creatures that fed on mosquitoes and their eggs. Sugar curing house, 1762 : Sugar pots and jars on sugar plantations served as breeding place for larvae of A. aegypti, the vector of yellow fever. Although yellow fever is most prevalent in tropical - like climates, the northern United States were not exempted from the fever. The first outbreak in English - speaking North America occurred in New York City in 1668, and a serious one afflicted Philadelphia in 1793. English colonists in Philadelphia and the French in the Mississippi River Valley recorded major outbreaks in 1669, as well as those occurring later in the 18th and 19th centuries. The southern city of New Orleans was plagued with major epidemics during the 19th century, most notably in 1833 and 1853. At least 25 major outbreaks took place in the Americas during the 18th and 19th centuries, including particularly serious ones in Cartagena in 1741, Cuba in 1762 and 1900, Santo Domingo in 1803, and Memphis in 1878. Considerable debate existed over whether the number of deaths caused by disease in the Haitian Revolution of the 1780s was exaggerated. Major outbreaks have also occurred in southern Europe. Gibraltar lost many to outbreaks in 1804, 1814, and 1828. Barcelona suffered the loss of several thousand citizens during an outbreak in 1821. Urban epidemics continued in the United States until 1905, with the last outbreak affecting New Orleans. In Colonial times and during the Napoleonic Wars, the West Indies were known as a particularly dangerous posting for soldiers due to the presence of yellow fever. The mortality rate in British garrisons in Jamaica was seven times that of garrisons in Canada, mostly because of yellow fever and other tropical disease such as malaria. Both English and French forces posted there were seriously affected by the `` yellow jack ''. Wanting to regain control of the lucrative sugar trade in Saint - Domingue ( Hispaniola ), and with an eye on regaining France 's New World empire, Napoleon sent an army under the command of his brother - in - law to Saint - Domingue to seize control after a slave revolt. The historian J.R. McNeill asserts that yellow fever accounted for about 35,000 to 45,000 casualties of these forces during the fighting. Only one - third of the French troops survived for withdrawal and return to France. Napoleon gave up on the island, and in 1804, Haiti proclaimed its independence as the second republic in the Western Hemisphere. Yellow fever epidemic of 1878 can still be found in New Orleans ' cemeteries. The yellow fever epidemic of 1793 in Philadelphia, which was then the capital of the United States, resulted in the deaths of several thousand people, more than 9 % of the population. The national government fled the city, including President George Washington. Additional yellow fever epidemics struck Philadelphia, Baltimore, and New York City in the 18th and 19th centuries, and traveled along steamboat routes from New Orleans. They caused some 100,000 -- 150,000 deaths in total. In 1853, Cloutierville, Louisiana, had a late - summer outbreak of yellow fever that quickly killed 68 of the 91 inhabitants. A local doctor concluded that some unspecified infectious agent had arrived in a package from New Orleans. In 1858, St. Matthew 's German Evangelical Lutheran Church in Charleston, South Carolina, suffered 308 yellow fever deaths, reducing the congregation by half. A ship carrying persons infected with the virus arrived in Hampton Roads in southeastern Virginia in June 1855. The disease spread quickly through the community, eventually killing over 3,000 people, mostly residents of Norfolk and Portsmouth. In 1873, Shreveport, Louisiana, lost almost a quarter of its population to yellow fever. In 1878, about 20,000 people died in a widespread epidemic in the Mississippi River Valley. That year, Memphis had an unusually large amount of rain, which led to an increase in the mosquito population. The result was a huge epidemic of yellow fever. The steamship John D. Porter took people fleeing Memphis northward in hopes of escaping the disease, but passengers were not allowed to disembark due to concerns of spreading yellow fever. The ship roamed the Mississippi River for the next two months before unloading her passengers. The last major U.S. outbreak was in 1905 in New Orleans. Ezekiel Stone Wiggins, known as the Ottawa Prophet, proposed that the cause of a yellow fever epidemic in Jacksonville, Florida, in 1888, was astronomical. The planets were in the same line as the sun and earth and this produced, besides Cyclones, Earthquakes, etc., a denser atmosphere holding more carbon and creating microbes. Mars had an uncommonly dense atmosphere, but its inhabitants were probably protected from the fever by their newly discovered canals, which were perhaps made to absorb carbon and prevent the disease. Yellow fever in Buenos Aires, 1871 In 1848, Josiah C. Nott suggested that yellow fever was spread by insects such as moths or mosquitoes, basing his ideas on the pattern of transmission of the disease. Carlos Finlay, a Cuban doctor and scientist, proposed in 1881 that yellow fever might be transmitted by mosquitoes rather than direct human contact. Since the losses from yellow fever in the Spanish -- American War in the 1890s were extremely high, Army doctors began research experiments with a team led by Walter Reed, composed of doctors James Carroll, Aristides Agramonte, and Jesse William Lazear. They successfully proved Finlay 's '' mosquito hypothesis ''. Yellow fever was the first virus shown to be transmitted by mosquitoes. The physician William Gorgas applied these insights and eradicated yellow fever from Havana. He also campaigned against yellow fever during the construction of the Panama Canal, after a previous effort on the part of the French failed ( in part due to mortality from the high incidence of yellow fever and malaria, which killed many workers ). Although Dr. Reed has received much of the credit in United States history books for `` beating '' yellow fever, he had fully credited Dr. Finlay with the discovery of the yellow fever vector, and how it might be controlled. Reed often cited Finlay 's papers in his own articles, and also gave him credit for the discovery in his personal correspondence. The acceptance of Finlay 's work was one of the most important and far - reaching effects of the Walter Reed Commission of 1900. Applying methods first suggested by Finlay, the United States government and Army eradicated yellow fever in Cuba and later in Panama, allowing completion of the Panama Canal. While Reed built on the research of Carlos Finlay, historian François Delaporte notes that yellow fever research was a contentious issue. Scientists, including Finlay and Reed, became successful by building on the work of less prominent scientists, without always giving them the credit they were due. Reed 's research was essential in the fight against yellow fever. He should also receive full credit for his use of the first type of medical consent form during his experiments in Cuba, an attempt to ensure that participants knew they were taking a risk by being part of testing. Max Theiler Like Cuba and Panama, Brazil also led a highly successful sanitation campaign against yellow fever. Beginning in 1903, the campaign led by Oswaldo Goncalves Cruz, then director general of public health, would come not only to eradicate the disease, but to reshape the physical landscape of Brazilian cities, like Rio de Janeiro, as well. During rainy seasons Rio de Janeiro regularly experienced floods, as water from the bay surrounding the city overflowed into Rio 's narrow streets. This coupled with the poor drainage systems found throughout Rio, created swampy conditions in the city 's neighborhoods. Pools of stagnant water stood year long in city streets and proved to be a fertile ground for disease carrying mosquitoes. Thus, under Cruz 's direction public health units known as `` mosquito inspectors '' fiercely worked to combat yellow fever throughout Rio by spraying, exterminating rats, and destroying unsanitary housing. Ultimately, the city 's sanitation and renovation campaigns reshaped Rio de Janeiro 's neighborhoods as its poor residents were pushed from city centers to Rio 's suburbs or to towns found in the outskirts of the city. In later years, Rio 's most impoverished inhabitants would come to reside in favelas. During 1920 -- 23, the Rockefeller Foundation 's International Health Board undertook an expensive and successful yellow fever eradication campaign in Mexico. The IHB gained the respect of Mexico 's federal government because of the success. The eradication of yellow fever strengthened the relationship between the US and Mexico, which had not been very good in the past. The eradication of yellow fever was also a major step toward better global health. In 1927, scientists isolated the yellow fever virus in West Africa. Following this, two vaccines were developed in the 1930s. The vaccine 17D was developed by the South African microbiologist Max Theiler at the Rockefeller Institute in New York City. This vaccine was widely used by the U.S. Army during World War II. Following the work of Ernest Goodpasture, Theiler used chicken eggs to culture the virus and won a Nobel Prize in 1951 for this achievement. A French team developed the French neurotropic vaccine ( FNV ), which was extracted from mouse brain tissue. Since this vaccine was associated with a higher incidence of encephalitis, FNV was not recommended after 1961. Vaccine 17D is still in use, and more than 400 million doses have been distributed. Little research has been done to develop new vaccines. Some researchers worry that the 60 - year - old technology for vaccine production may be too slow to stop a major new yellow - fever epidemic. Newer vaccines, based on vero cells, are in development and should replace 17D at some point. Using vector control and strict vaccination programs, the urban cycle of yellow fever was nearly eradicated from South America. Since 1943, only a single urban outbreak in Santa Cruz de la Sierra, Bolivia, has occurred. Since the 1980s, though, the number of yellow fever cases has been increasing again, and A. aegypti has returned to the urban centers of South America. This is partly due to limitations on available insecticides, as well as habitat dislocations caused by climate change. It is also because the vector control program was abandoned. Although no new urban cycle has yet been established, scientists believe this could happen again at any point. An outbreak in Paraguay in 2008 was thought to be urban in nature, but this ultimately proved not to be the case. In Africa, virus eradication programs have mostly relied upon vaccination. These programs have largely been unsuccessful because they were unable to break the sylvatic cycle involving wild primates. With few countries establishing regular vaccination programs, measures to fight yellow fever have been neglected, making the future spread of the virus more likely. Research In the hamster model of yellow fever, early administration of the antiviral ribavirin is an effective early treatment of many pathological features of the disease. Ribavirin treatment during the first five days after virus infection improved survival rates, reduced tissue damage in the liver and spleen, prevented hepatocellular steatosis, and normalised levels of alanine aminotransferase, a liver damage marker. The mechanism of action of ribavirin in reducing liver pathology in yellow fever virus infection may be similar to its activity in treatment of hepatitis C, a related virus. Because ribavirin had failed to improve survival in a virulent rhesus model of yellow fever infection, it had been previously discounted as a possible therapy. Infection was reduced in mosquitoes with the wMel strain of Wolbachia. Yellow fever has been researched by several countries as a potential biological weapon. References ^ Jump up to : Oldstone, Michael ( 2009 ). Viruses, Plagues, and History : Past, Present and Future. Oxford University Press. pp. 102 -- 4. ISBN 9780199758494. Archived from the original on 2017 - 02 - 23. Jump up ^ Bazin, Hervé ( 2011 ). Vaccination : a history from Lady Montagu to genetic engineering. Montrouge : J. Libbey Eurotext. p. 407. ISBN 9782742007752. Archived from the original on 2017 - 02 - 23. ^ Jump up to : `` Yellow fever Fact sheet N ° 100 ''. World Health Organization. May 2013. Archived from the original on 19 February 2014. Retrieved 23 February 2014. ^ Jump up to : Tolle MA ( April 2009 ). `` Mosquito - borne diseases ''. Curr Probl Pediatr Adolesc Health Care. 39 ( 4 ) : 97 -- 140. doi : 10.1016 / j. cppeds. 2009.01. 001. PMID 19327647. Jump up ^ GBD 2015 Mortality and Causes of Death, Collaborators. ( 8 October 2016 ). `` Global, regional, and national life expectancy, all - cause mortality, and cause - specific mortality for 249 causes of death, 1980 -- 2015 : a systematic analysis for the Global Burden of Disease Study 2015 ''. Lancet. 388 ( 10053 ) : 1459 -- 1544. doi : 10.1016 / s0140 - 6736 ( 16 ) 31012 - 1. PMID 27733281. Jump up ^ Scully, Crispian ( 2014 ). Scully 's Medical Problems in Dentistry. Elsevier Health Sciences. p. 572. ISBN 9780702059636. Archived from the original on 2017 - 02 - 20. ^ Jump up to : Lindenbach, B.D. ; et al. ( 2007 ). `` Flaviviridae : The Viruses and Their Replication ''. In Knipe, D.M. ; P.M. Howley. Fields Virology ( 5th ed. ). Philadelphia, PA : Lippincott Williams & Wilkins. p. 1101. ISBN 0 - 7817606 - 0 - 7. Jump up ^ `` Frequently Asked Questions About Yellow Fever ''. CDC. August 21, 2015. Archived from the original on 23 March 2016. Retrieved 18 March 2016. Jump up ^ `` CDC Yellow Fever ''. Archived from the original on 2012 - 12 - 21. Retrieved 2012 - 12 - 12. ^ Jump up to : Barrett AD, Higgs S ( 2007 ). `` Yellow fever : a disease that has yet to be conquered ''. Annu. Rev. Entomol. 52 : 209 -- 29. doi : 10.1146 / annurev. ento. 52.110405. 091454. PMID 16913829. Jump up ^ Sfakianos, Jeffrey ; Hecht, Alan ( 2009 ). Babcock, Hilary, ed. West Nile virus. Foreword by David Heymann ( 2nd ed. ). New York : Chelsea House. p. 17. ISBN 9781604132540. Archived from the original on 2017 - 02 - 23. Jump up ^ `` CDC : Yellow fever -- Symptoms and treatment ''. Archived from the original on 2012 - 03 - 21. Retrieved 2010 - 11 - 10. Jump up ^ `` Yellow fever ''. WHO. Archived from the original on 2009 - 08 - 17. Retrieved 2009 - 08 - 13. Jump up ^ Control of Communicable Diseases Manual ( 20th ed. ). Amer Public Health Assn. ISBN 978 - 0875530185. Jump up ^ Chastel C ( August 2003 ). `` ( Centenary of the discovery of yellow fever virus and its transmission by a mosquito ( Cuba 1900 -- 1901 ) ) ''. Bull Soc Pathol Exot ( in French ). 96 ( 3 ) : 250 -- 6. PMID 14582304. Jump up ^ Dr. Irwin Sherman `` Twelve Diseases that Changed Our World ''. P. 144. ASM Press. 2007. ISBN 978 - 1 - 55581 - 466 - 3. OCLC 141178241. Jump up ^ Franklin, Jon ; Sutherland, John. `` Guinea Pig Doctors : The Drama of Medical Research Through Self - Experimentation '' by Jon Franklin ( Author ), John Sutherland ( Author ) Publisher : William Morrow & Co ( March 1984 ) ISBN 068 - 8 - 02666 - 4 ^ Jump up to : Monath TP ( April 2008 ). `` Treatment of yellow fever ''. Antiviral Res. 78 ( 1 ) : 116 -- 24. doi : 10.1016 / j. antiviral. 2007.10. 009. PMID 18061688. Jump up ^ `` Yellow fever, Complications Archived 2016 - 07 - 23 at the Wayback Machine., '' Mayo Clinic Archived 2016 - 07 - 21 at the Wayback Machine., 2014 - 08 - 20. Retrieved 2016 - 07 - 25. Jump up ^ Tomori O ( 2004 ). `` Yellow fever : the recurring plague ''. Crit Rev Clin Lab Sci. 41 ( 4 ) : 391 -- 427. doi : 10.1080 / 10408360490497474. PMID 15487593. Jump up ^ Modrow, S. ; et al. ( 2002 ). Molekulare Virologie -- Eine Einführung für Biologen und Mediziner ( 2nd ed. ). Spektrum Akademischer Verlag. p. 182. ISBN 3 - 8274 - 1086 - X. Jump up ^ Rogers DJ, Wilson AJ, Hay SI, Graham AJ ( 2006 ). `` The global distribution of yellow fever and dengue ''. Adv. Parasitol. 62 : 181 -- 220. doi : 10.1016 / S0065 - 308X ( 05 ) 62006 - 4. PMC 3164798. PMID 16647971. Jump up ^ Staples JE, Monath TP ( Aug 27, 2008 ). `` Yellow fever : 100 years of discovery ''. JAMA : The Journal of the American Medical Association. 300 ( 8 ) : 960 -- 2. doi : 10.1001 / jama. 300.8. 960. PMID 18728272. ^ Jump up to : Sampath A, Padmanabhan R ( January 2009 ). `` Molecular targets for flavivirus drug discovery ''. Antiviral Research. 81 ( 1 ) : 6 -- 15. doi : 10.1016 / j. antiviral. 2008.08. 004. PMC 2647018. PMID 18796313. Jump up ^ Silva, Patricia A.G.C. ( 2010 ). `` An RNA Pseudoknot Is Required for Production of Yellow Fever Virus Subgenomic RNA by the Host Nuclease XRN1 ''. Journal of Virology. 84 : 11395 -- 11406. doi : 10.1128 / jvi. 01047 - 10. PMC 2953177. PMID 20739539. Archived from the original on 2017 - 09 - 08. Jump up ^ Fontenille D, Diallo M, Mondo M, Ndiaye M, Thonnon J ( 1997 ). `` First evidence of natural vertical transmission of yellow fever virus in Aedes aegypti, its epidemic vector ''. Transactions of the Royal Society of Tropical Medicine and Hygiene. 91 ( 5 ) : 533 -- 5. doi : 10.1016 / S0035 - 9203 ( 97 ) 90013 - 4. PMID 9463659. Jump up ^ `` Infectious Diseases Related to Travel ''. Yellow Book. Centers for Disease Control and Prevention. Archived from the original on 20 March 2016. Retrieved 20 March 2016. Jump up ^ `` Yellow fever fact sheet ''. WHO -- Yellow fever. Archived from the original on 2006 - 04 - 18. Retrieved 2006 - 04 - 18. Jump up ^ `` Ebola outbreak Alert and response operations Diseases Biorisk reduction Yellow fever : a current threat ''. WHO. Archived from the original on 8 August 2016. Retrieved 4 August 2016. Jump up ^ Ryan, K.J. ; C.G. Ray., eds. ( 2004 ). Sherris Medical Microbiology ( 4th ed. ). McGraw Hill. ISBN 0 - 8385 - 8529 - 9. Jump up ^ Quaresma JA, Barros VL, Pagliari C, Fernandes ER, Guedes F, Takakura CF, Andrade HF, Vasconcelos PF, Duarte MI ( 2006 ). `` Revisiting the liver in human yellow fever : virus - induced apoptosis in hepatocytes associated with TGF - beta, TNF - alpha and NK cells activity ''. Virology. 345 ( 1 ) : 22 -- 30. doi : 10.1016 / j. virol. 2005.09. 058. PMID 16278000. Jump up ^ `` Prevention Yellow Fever CDC ''. www.cdc.gov. Archived from the original on 2016 - 10 - 26. Retrieved 2016 - 10 - 26. ^ Jump up to : Barrett AD, Teuwen DE ( June 2009 ). `` Yellow fever vaccine -- how does it work and why do rare cases of serious adverse events take place ? ''. Current Opinion in Immunology. 21 ( 3 ) : 308 -- 13. doi : 10.1016 / j. coi. 2009.05. 018. PMID 19520559. Jump up ^ WHO Yellow fever vaccination booster not needed Archived 2013 - 06 - 09 at the Wayback Machine... Who.int ( 2013 - 05 - 17 ). Retrieved on 2014 - 05 - 12. Jump up ^ Yellow Fever Vaccine Information Statement. Archived 2013 - 09 - 21 at the Wayback Machine. Centers for Disease Control and Prevention. March 30, 2011. Jump up ^ `` Yellow fever ''. World Health Organization. Archived from the original on 18 April 2017. Retrieved 2 April 2017. Jump up ^ `` Twelve million West Africans get yellow fever vaccines ''. BBC News. 23 November 2009. Archived from the original on 8 September 2017. Retrieved 23 November 2009. Jump up ^ `` WHO dispatched 3.5 million doses of yellow fever vaccine for outbreak response in Brazil ''. World Health Organization. Archived from the original on 1 April 2017. Retrieved 2 April 2017. Jump up ^ `` Yellow fever -- Brazil ''. World Health Organization. Archived from the original on 6 March 2017. Retrieved 9 March 2017. Jump up ^ `` Country list : Yellow fever vaccination requirements and recommendations ; malaria situation ; and other vaccination requirements '' ( PDF ). WHO. 2013. p. 32. Archived ( PDF ) from the original on 2015 - 04 - 05. Retrieved 2015 - 04 - 12. Jump up ^ `` Yellow Fever -- China ''. World Health Organization. Archived from the original on 19 March 2017. Retrieved 9 February 2017. Jump up ^ Woodall, J.P. ; Yuill, T.M. ( July 2016 ). `` Why is the yellow fever outbreak in Angola a ' threat to the entire world ' ? ''. International Journal of Infectious Diseases. 48 : 96 -- 97. doi : 10.1016 / j. ijid. 2016.05. 001. Jump up ^ Mutebi JP, Barrett AD ( 2002 ). `` The epidemiology of yellow fever in Africa ''. Microbes Infect. 4 ( 14 ) : 1459 -- 1468. doi : 10.1016 / S1286 - 4579 ( 02 ) 00028 - X. PMID 12475636. Jump up ^ Ellis BR, Barrett AD ( 2008 ). `` The enigma of yellow fever in East Africa ''. Rev Med Virol. 18 ( 5 ) : 331 -- 346. doi : 10.1002 / rmv. 584. PMID 18615782. Jump up ^ Mutebi JP, Rijnbrand RC, Wang H, Ryman KD, Wang E, Fulop LD, Titball R, Barrett AD ( 2004 ). `` Genetic relationships and evolution of genotypes of yellow fever virus and other members of the yellow fever virus group within the Flavivirus genus based on the 3 ' noncoding region ''. J Virol. 78 ( 18 ) : 9652 -- 9665. doi : 10.1128 / JVI. 78.18. 9652 - 9665.2004. PMC 515011. PMID 15331698. ^ Jump up to : Auguste AJ, Lemey P, Pybus OG, Suchard MA, Salas RA, Adesiyun AA, Barrett AD, Tesh RB, Weaver SC, Carrington CV ( 2010 ). `` Yellow fever virus maintenance in Trinidad and its dispersal throughout the Americas ''. J Virol. 84 ( 19 ) : 9967 -- 9977. doi : 10.1128 / JVI. 00588 - 10. PMC 2937779. PMID 20631128. Jump up ^ de Souza RP, Foster PG, Sallum MA, Coimbra TL, Maeda AY, Silveira VR, Moreno ES, da Silva FG, Rocco IM, Ferreira IB, Suzuki A, Oshiro FM, Petrella SM, Pereira LE, Katz G, Tengan CH, Siciliano MM, Dos Santos CL ( 2010 ). `` Detection of a new yellow fever virus lineage within the South American genotype I in Brazil ''. J Med Virol. 82 ( 1 ) : 175 -- 185. doi : 10.1002 / jmv. 21606. PMID 19950229. Jump up ^ `` YELLOW FEVER - AMERICAS ( 01 ) : PAHO / WHO 2016 ''. www.promedmail.org. International Society for Infectious Diseases. Archived from the original on 16 February 2017. Retrieved 16 February 2017. Jump up ^ `` Yellow fever killing thousands of monkeys in Brazil ''. www.sciencedaily.com. Archived from the original on 24 March 2017. Retrieved 24 March 2017. Jump up ^ `` Yellow fever -- Brazil ''. World Health Organization. Archived from the original on 9 April 2017. Retrieved 9 April 2017. Jump up ^ `` ProMED - mail post Yellow fever - Americas ( 47 ) : Brazil, PAHO / WHO ''. www.promedmail.org. International Society for Infectious Diseases. Archived from the original on 8 September 2017. Retrieved 1 June 2017. Jump up ^ Times, Global. `` Yellow fever cases continue to rise in Brazil, 253 confirmed -- Global Times ''. www.globaltimes.cn. Archived from the original on 19 February 2017. Retrieved 19 February 2017. Jump up ^ `` Yellow Fever in Brazil - Alert - Level 2, Practice Enhanced Precautions - Travel Health Notices Travelers ' Health CDC ''. wwwnc.cdc.gov. Archived from the original on 25 May 2017. Retrieved 1 June 2017. Jump up ^ Mir D, Delatorre E, Bonaldo M, Lourenço - de-Oliveira R, Vicente AC, Bello G ( 2017 ) Phylodynamics of Yellow Fever Virus in the Americas : new insights into the origin of the 2017 Brazilian outbreak. Sci Rep 7 ( 1 ) : 7385 Jump up ^ Vainio J. ; F. Cutts, eds. ( 1998 ). Yellow Fever. WHO Division of Emerging and other Communicable Diseases Surveillance and Control. Jump up ^ Monath, T.P. ( 1989 ). `` The absence of yellow fever in Asia : hypotheses. A cause for concern ? ''. Virus Inf Exch Newslett : 106 -- 7. Jump up ^ Cathey JT, Marr JS ( 2014 ). `` Yellow fever, Asia and the East African slave trade ''. Trans R Soc Trop Med Hyg. 108 ( 5 ) : 252 -- 7. doi : 10.1093 / trstmh / tru043. PMID 24743951. Jump up ^ Bryant JE, Holmes EC, Barrett AD ( 2007 ). `` Out of Africa : a molecular perspective on the introduction of yellow fever virus into the Americas ''. PLoS Pathog. 3 ( 5 ) : e75. doi : 10.1371 / journal. ppat. 0030075. PMC 1868956. PMID 17511518. Jump up ^ Gould EA, de Lamballerie X, Zanotto PM, Holmes EC ( 2003 ). `` Origins, evolution, coadaptations within the genus Flavivirus ''. Advances in Virus Research. 59 : 277 -- 314. doi : 10.1016 / S0065 - 3527 ( 03 ) 59008 - X. ISBN 9780120398591. PMID 14696332. Jump up ^ Bryant, JE ; Holmes, EC ; Barrett, AD ( 18 May 2007 ). `` Out of Africa : a molecular perspective on the introduction of yellow fever virus into the Americas ''. PLOS Pathogens. 3 ( 5 ) : e75. doi : 10.1371 / journal. ppat. 0030075. PMC 1868956. PMID 17511518. Jump up ^ Oldstone, M. ( 1998 ). Viruses, Plagues, and History, New York : Oxford University Press. Jump up ^ McNeill, J.R. ( 2010 ). Mosquito Empires : Ecology and war in the greater Caribbean, 1620 -- 1914. NY : Cambridge University Press. pp. 44 -- 45. ^ Jump up to : McNeill, J.R. ( 1 April 2004 ). `` Yellow Jack and Geopolitics : Environment, Epidemics, and the Struggles for Empire in the American Tropics, 1650 -- 1825 ''. OAH Magazine of History. 18 ( 3 ) : 9 -- 13. doi : 10.1093 / maghis / 18.3. 9. Archived from the original on 20 December 2016. Jump up ^ The earliest mention of `` yellow fever '' appears in a manuscript of 1744 by Dr. John Mitchell of Virginia ; copies of the manuscript were sent to Mr. Cadwallader Colden, a physician in New York, and to Dr. Benjamin Rush of Philadelphia ; the manuscript was eventually printed ( in large part ) in 1805 and reprinted in 1814. See : ( John Mitchell ) ( 1805 ) ( Mitchell 's account of the Yellow Fever in Virginia in 1741 -- 2 ) Archived 2017 - 02 - 23 at the Wayback Machine., The Philadelphia Medical Museum, 1 ( 1 ) : 1 -- 20. ( John Mitchell ) ( 1814 ) `` Account of the Yellow fever which prevailed in Virginia in the years 1737, 1741, and 1742, in a letter to the late Cadwallader Colden, Esq. of New York, from the late John Mitchell, M.D.F.R.S. of Virginia, '' Archived 2017 - 02 - 23 at the Wayback Machine. American Medical and Philosophical Register, 4 : 181 -- 215. The term `` yellow fever '' appears on p. 186. On p. 188, Mitchell mentions ``... the distemper was what is generally called the yellow fever in America. '' However, on pages 191 -- 192, he states ``... I shall consider the cause of the yellowness which is so remarkable in this distemper, as to have given it the name of the Yellow Fever. '' However, that Dr. Mitchell misdiagnosed the disease that he observed and treated, and the disease was probably Weil 's disease or hepatitis. See : Jarcho S ( 1957 ). `` John Mitchell, Benjamin Rush, and yellow fever ''. Bull Hist Med. 31 ( 2 ) : 132 -- 6. PMID 13426674. Jump up ^ McNeill, John ( 2010 ). Mosquito Empires : Ecology and War in the Greater Caribbean, 1620 -- 1914. New York, NY : Cambridge University Press. ISBN 978 - 0 - 511 - 67268 - 2. Jump up ^ Miller, Jacquelyn C ( 2005 ). `` The Wages of Blackness : African American Workers and the Meanings of Race during Philadelphia 's 1793 Yellow Fever Epidemic ''. The Pennsylvania Magazine of History and Biography. 129 ( 2 ) : 163 -- 194. Jump up ^ John S. Marr, and John T. Cathey. `` The 1802 Saint - Domingue yellow fever epidemic and the Louisiana Purchase. '' Journal of Public Health Management and Practice 19 #. 1 ( 2013 ) : 77 -- 82. online Archived 2016 - 02 - 04 at the Wayback Machine. Jump up ^ Philippe R. Girard ( 2011 ). The Slaves Who Defeated Napoleon : Toussaint Louverture and the Haitian War of Independence, 1801 -- 1804. University of Alabama Press. pp. 179 -- 80. Archived from the original on 2016 - 09 - 11. Jump up ^ `` Gibraltar 's 1804 Yellow Fever Scourge : The Search for Scapegoats ''. Oxford Journals -- Journal of the History of Medicine and Allied Sciences. Archived from the original on 2011 - 08 - 22. Retrieved 2013 - 04 - 05. Jump up ^ John Pierce & Jim Writer ( 2005 ). Yellow Jack : How Yellow Fever ravaged America and Walter Reed Discovered Its Deadly Secrets. Hoboken : John Wiley & Sons. p. 3. Jump up ^ McNeill, JR ( 2002 ). `` Yellow fever and geopolitics : environment, epidemics, and the struggles for empire in the American tropics, 1650 -- 1900 ''. History now ( Christchurch, N.Z. ). 8 ( 2 ) : 10 -- 6. PMID 20690235. Jump up ^ McNeill, J.R. ( 2010 ). Moaquito Empires : Ecology and war in the greater Caribbean, 1620 -- 1914. Cambridge University Press. p. 259. Jump up ^ `` Yellow Fever Attacks Philadelphia, 1793 ''. EyeWitness to History. Archived from the original on 2007 - 06 - 07. Retrieved 2009 - 08 - 14. Jump up ^ Patterson KD ( 1992 ). `` Yellow fever epidemics and mortality in the United States, 1693 -- 1905 ''. Social science & medicine ( 1982 ). 34 ( 8 ) : 855 -- 865. doi : 10.1016 / 0277 - 9536 ( 92 ) 90255 - O. PMID 1604377. Jump up ^ The Transactions of the American Medical Association, Volume IX, TK and PG Collins, 1856, page 704, `` Yellow Fever at the Village of Cloutierville, La, in the Years 1853 and 1854 '' by Samuel O. Scruggs, M.D. Jump up ^ New Orleans Genesis June 1970, page 261 - 262, `` Cloutierville Yellow Fever Deaths, 1853 '' Jump up ^ St. Matthew 's Evangelical Lutheran Church : 125 Years of Christian Service, 1967. Jump up ^ Mauer HB. `` Mosquito control ends fatal plague of yellow fever ''. etext.lib.virginia.edu. Retrieved 2007 - 06 - 11. ( undated newspaper clipping ). Jump up ^ Crosby, Molly Caldwell ( 2006 ). The American Plague. New York : Berkley Publishing Group. p. 75. Jump up ^ `` Yellow Fever -- the plague of Memphis ''. HistoricMemphis.com. Archived from the original on August 21, 2014. Retrieved August 20, 2014. Jump up ^ Barnes, E. ( 2005 ). Diseases and Human Evolution. Albuquerque : University of New Mexico. ISBN 0 - 8263 - 3065 - 7. Jump up ^ `` The Tennessee Encyclopedia of History and Culture : Yellow Fever Epidemics ''. Tennessee Historical Society. Archived from the original on December 12, 2013. Retrieved June 20, 2013. Jump up ^ John W. Cowart, `` Yellow Jack in Jacksonville, Yellow Fever visited Duval County, Florida, in 1888 '' Archived 2013 - 01 - 05 at the Wayback Machine., Historical Text Archive Jump up ^ Josiah C. Nott ( 1848 ) `` Yellow Fever contrasted with Bilious Fever -- Reasons for believing it a disease sui generis -- Its mode of Propagation -- Remote Cause -- Probable insect or animalcular origin '' `` The New Orleans Medical and Surgical Journal, '' `` 4 '' : 563 -- 601. Jump up ^ Carlos Juan Finlay ( presented : August 14, 1881 ; published : 1882 ) `` El mosquito hipoteticamente considerado como agente de trasmision de la fiebre amarilla '' Archived 2017 - 02 - 23 at the Wayback Machine. ( The mosquito hypothetically considered as an agent in the transmission of yellow fever ) Anales de la Real Academia de Ciencias Médicas, Físicas y Naturales de la Habana, 18 : 147 -- 169. Available on - line in English at : Charles Finlay, with Rudolph Matas, translator ( 1881 ) `` The mosquito hypothetically considered as an agent in the transmission of yellow fever poison, '' Archived 2017 - 02 - 23 at the Wayback Machine. New Orleans Medical and Surgical Journal, 9 : 601 -- 616. Delta Omega.org Archived 2012 - 05 - 09 at the Wayback Machine. Jump up ^ Chaves - Carballo E ( 2005 ). `` Carlos Finlay and yellow fever : triumph over adversity ''. Mil Med. 170 ( 10 ) : 881 -- 5. doi : 10.7205 / milmed. 170.10. 881. PMID 16435764. Jump up ^ Pierce, J.R. ; Writer, J. ( 2005 ). Yellow Jack : How Yellow Fever Ravaged America and Walter Reed Discovered Its Deadly Secrets. Wiley. ISBN 0 - 471 - 47261 - 1. Jump up ^ `` U.S. Army Yellow Fever Commission ''. UVA Health Sciences : Historical Collections. Archived from the original on 2017 - 04 - 26. Retrieved 2017 - 08 - 01. Jump up ^ Delaporte, Francois ( 1991 ). The History of Yellow Fever : An Essay on the Birth of Tropical Medicine. Cambridge : MIT Press. pp. 89 -- 90. Jump up ^ Crosby, Molly Caldwell ( 2006 ). The American Plague :. New York : Berkley Publishing Group. p. 177. Jump up ^ Teresa A. Meade, A History of Modern Latin America : 1800 To The Present, 1st ed. ( Chichester : Wiley - Blackwell, 2010 ), 148 - 149. Jump up ^ Fosdick, Raymond B. ( 1952 ). The Story of the Rockefeller Foundation. New York : Harper & Brothers. pp. 58 -- 79. Jump up ^ Birn AE, Solórzano A ( 1999 ). `` Public health policy paradoxes : science and politics in the Rockefeller Foundation 's hookworm campaign in Mexico in the 1920s ''. Soc Sci Med. 49 ( 9 ) : 1197 -- 213. doi : 10.1016 / s0277 - 9536 ( 99 ) 00160 - 4. PMID 10501641. Jump up ^ L. Bigon ( 2014 ), `` Transnational Networks of Administrating Disease and Urban Planning in West Africa : The Inter-Colonial Conference on Yellow Fever, Dakar, 1928 '' GeoJournal, 79 ( 1 ) : 103 -- 111. ^ Jump up to : Sbrana E, Xiao SY, Guzman H, Ye M, Travassos da Rosa AP, Tesh RB ( 2004 ). `` Efficacy of post-exposure treatment of yellow fever with ribavirin in a hamster model of the disease ''. Am J Trop Med Hyg. 71 ( 3 ) : 306 -- 12. PMID 15381811. Jump up ^ Huggins JW ( 1989 ). `` Prospects for treatment of viral hemorrhagic fevers with ribavirin, a broad - spectrum antiviral drug ''. Rev Infect Dis. 11 ( Suppl 4 ) : S750 -- 61. doi : 10.1093 / clinids / 11. Supplement_4. S750. PMID 2546248. Jump up ^ http://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0001892 Archived 2016 - 05 - 09 at the Wayback Machine. Impact of Wolbachia on Infection with Chikungunya and Yellow Fever Viruses in the Mosquito Vector Aedes aegypti Jump up ^ Endicott, S.L. ; Hageman, E. ( 1998 ). The United States and Biological Warfare : Secrets from the Early Cold War and Korea. Indiana University Press. ISBN 0 - 253 - 33472 - 1. Further reading Crosby, M. ( 2006 ). The American Plague : The Untold Story of Yellow Fever, the Epidemic that Shaped Our History. New York : The Berkley Publishing Group. ISBN 0 - 425 - 21202 - 5. Espinosa, M. ( 2009 ). Epidemic Invasions : Yellow Fever and the Limits of Cuban Independence, 1878 -- 1930. Chicago : University of Chicago Press. ISBN 978 - 0 - 226 - 21811 - 3. Murphy, J. ( 2003 ). An American Plague : The True and Terrifying Story of the Yellow Fever Epidemic of 1793. New York : Clarion Books. ISBN 0 - 395 - 77608 - 2. Nuwer, D.S. ( 2009 ). Plague Among the Magnolias : The 1878 Yellow Fever Epidemic in Mississippi. University of Alabama Press. ISBN 978 - 0 - 8173 - 1653 - 2. External links Classification V T D ICD - 10 : A95 ICD - 9 - CM : 060 MeSH : D015004 DiseasesDB : 14203 External resources MedlinePlus : 001365 eMedicine : med / 2432 emerg / 645 Medicine portal Viruses portal Wikivoyage has a travel guide for Yellow fever. Wikipedia 's health care articles can be viewed offline with the Medical Wikipedia app. Yellow fever at Curlie ( based on DMOZ ) Finlay CJ ( 2012 ). `` The Mosquito Hypothetically Considered as the Transmitting Agent of Yellow Fever ''. MEDICC Review. 14 ( 1 ) : 56 -- 9. `` U.S. Army Yellow Fever Commission. '' Claude Moore Health Sciences Library, University of Virginia `` Yellow fever virus ''. NCBI Taxonomy Browser. 11089. Zoonotic viral diseases ( A80 -- B34, 042 -- 079 ) Arthropod - borne Mosquito - borne Bunyavirales Arbovirus encephalitides : La Crosse encephalitis LACV Batai virus ( BATV ) Bwamba Fever ( BWAV ) California encephalitis CEV Jamestown Canyon virus Tete virus Tahyna virus ( TAHV ) Viral hemorrhagic fevers : Rift Valley fever RVFV Bunyamwera fever ( BUNV ) Ngari virus ( NRIV ) Flaviviridae Arbovirus encephalitides : Japanese encephalitis JEV Australian encephalitis MVEV KUNV Saint Louis encephalitis SLEV Usutu virus West Nile fever WNV Viral hemorrhagic fevers : Dengue fever DENV - 1 - 4 Yellow fever YFV Zika fever Zika virus Togaviridae Arbovirus encephalitides : Eastern equine encephalomyelitis EEEV Western equine encephalomyelitis WEEV Venezuelan equine encephalomyelitis VEEV Chikungunya CHIKV O'Nyong - nyong fever ONNV Ross River fever RRV Semliki Forest virus Sindbis fever Reoviridae Banna virus encephalitis Tick - borne Bunyavirales Viral hemorrhagic fevers : Crimean -- Congo hemorrhagic fever CCHFV Heartland virus Bhanja virus Sandfly fever Naples virus Lone Star virus Tete virus Flaviviridae Arbovirus encephalitides : Tick - borne encephalitis TBEV Powassan encephalitis POWV Viral hemorrhagic fevers : Omsk hemorrhagic fever OHFV Kyasanur forest disease KFDV AHFV Langat virus ( LGTV ) Reoviridae Colorado tick fever CTFV Kemerovo tickborne viral fever Sandfly - borne Bunyavirales Adria virus ( ADRV ) Pappataci fever Toscana virus Sandfly fever Naples virus Oropouche fever Oropouche virus SFTS virus Rhabdoviridae Chandipura virus Mammal - borne Rodent - borne Arenaviridae Viral hemorrhagic fevers : Lassa fever LASV Venezuelan hemorrhagic fever GTOV Argentine hemorrhagic fever JUNV Brazilian hemorrhagic fever SABV Bolivian hemorrhagic fever MACV LUJV CHPV Bunyavirales Hemorrhagic fever with renal syndrome DOBV HTNV PUUV SEOV AMRV Hantavirus pulmonary syndrome ANDV SNV Bat - borne Filoviridae Viral hemorrhagic fevers : Ebola virus disease BDBV EBOV SUDV TAFV Marburg virus disease MARV RAVV Rhabdoviridae Rabies ABLV MOKV DUVV LBV CHPV Paramyxoviridae Henipavirus encephalitis HeV NiV Primate - borne Herpesviridae Herpes B virus Retroviridae Simian foamy virus HTLV - 1 HTLV - 2 Poxviridae Tanapox Yaba monkey tumor virus Multiple vectors Rhabdoviridae Rabies RABV Mokola virus Poxviridae Monkeypox GND : 4276496 - 8 NDL : 00568824 Retrieved from `` https://en.wikipedia.org/w/index.php?title=Yellow_fever&oldid=821700123 '' Categories : Yellow fever Biological weapons Epidemics Hidden categories : CS1 French - language sources ( fr ) Webarchive template wayback links All articles with dead external links Articles with dead external links from January 2018 Articles with permanently dead external links Infobox medical condition ( new ) Articles with ' species ' microformats Articles with medical app sidebar Articles with DMOZ links Wikipedia articles with GND identifiers RTT RTTID Talk Contents About Wikipedia Wikivoyage Afrikaans Azərbaycanca বাংলা Беларуская Български Bosanski Català Čeština Dansk Deutsch ދިވެހިބަސް Eesti Ελληνικά Español Esperanto Euskara فارسی Français Gaeilge Galego 한국어 Հայերեն हिन्दी Hrvatski Bahasa Indonesia Italiano עברית ಕನ್ನಡ Kaszëbsczi Kiswahili Kreyòl ayisyen Latviešu Lietuvių Lingála Luganda Magyar Македонски മലയാളം Bahasa Melayu Nederlands 日本 語 Norsk ଓଡ଼ିଆ Polski Português Română Runa Simi Русский Simple English Slovenščina Српски / srpski Srpskohrvatski / српскохрватски Suomi Svenska தமிழ் ไทย ትግርኛ Türkçe Thuɔŋjäŋ Українська اردو Tiếng Việt Yorùbá 粵語 中文 Edit links This page was last edited on 22 January 2018, at 02 : 56. Text is available under the Creative Commons Attribution - ShareAlike License ; additional terms may apply. By using this site, you agree to the Terms of Use and Privacy Policy. Wikipedia ® is a registered trademark of the Wikimedia Foundation, Inc., a non-profit organization. About Wikipedia

Question: who got rid of yellow fever in cuba
Answer: the United States government and Army